Lilly, Daiichi Explore Pharmacogenomic Marker For Prasugrel

Circulation study shows prasugrel metabolism unaffected by marker for Plavix non-response. Data won’t surprise FDA, but what will be the regulatory response?

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet